Maxcyte (MXCT) Net Cash Flow (2020 - 2026)
Maxcyte (MXCT) posted quarterly Net Cash Flow of -$5.5 million for Q1 2026, down 22.43% year-over-year from -$7.1 million in Q1 2025, and down 177.66% quarter-over-quarter from $7.1 million in Q4 2025.
Maxcyte (MXCT) Net Cash Flow (2020 - 2026) Analysis & Trends
Maxcyte (MXCT) has reported Net Cash Flow for 7 consecutive years, with -$5.5 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Net Cash Flow fell 22.43% year-over-year to -$5.5 million; the TTM figure through Mar 2026 stood at -$8.8 million (down 877.11% YoY), while the FY2025 annual figure was -$7.8 million, up 58.01% from the prior year.
- Net Cash Flow slipped to -$5.5 million in Q1 2026 per MXCT's latest filing, from $7.1 million in the prior quarter.
- Across five years, Net Cash Flow topped out at $192.0 million in Q1 2022 and bottomed at -$130.6 million in Q2 2022.
- Historically, Net Cash Flow has averaged -$2.0 million across 5 years, with a median of -$4.5 million in 2025.
- On a YoY basis, Net Cash Flow climbed as much as 220.27% in 2022 and fell as far as 406.95% in 2022.
- Maxcyte's Net Cash Flow stood at -$32.0 million in 2022, then surged by 91.66% to -$2.7 million in 2023, then plunged by 240.49% to -$9.1 million in 2024, then surged by 178.16% to $7.1 million in 2025, then plunged by 177.66% to -$5.5 million in 2026.
- Business Quant data shows MXCT's Net Cash Flow at -$5.5 million in Q1 2026, $7.1 million in Q4 2025, and -$2.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.20 Bn | 193.60 Bn | 7.27 Bn | -1.70 Bn |
| 2 | Stryker | 127.66 Bn | 124.19 Bn | 4.50 Bn | 527.00 Mn |
| 3 | Medtronic | 118.98 Bn | 109.76 Bn | 6.41 Bn | 768.00 Mn |
| 4 | Boston Scientific | 73.25 Bn | 72.71 Bn | 3.85 Bn | -892.00 Mn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 458.40 Mn |
| 6 | Dexcom | 34.37 Bn | 32.42 Bn | 830.00 Mn | -8.30 Mn |
| 7 | GE HealthCare Technologies | 33.89 Bn | 31.78 Bn | 2.18 Bn | -183.00 Mn |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | -926.40 Mn |
| 9 | Steris | 23.03 Bn | 22.55 Bn | 684.20 Mn | 45.10 Mn |
| 10 | Maxcyte | 148.48 Mn | 148.48 Mn | 5.60 Mn | 485,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 485,000.00 |
| Jun 30, 2026 | 485,000.00 |
| Mar 31, 2026 | -5.51 Mn |
| Mar 31, 2026 | -5.51 Mn |
| Dec 31, 2025 | 7.09 Mn |
| Dec 31, 2025 | 7.09 Mn |
| Sep 30, 2025 | -2.25 Mn |
| Sep 30, 2025 | -2.25 Mn |
| Jun 30, 2025 | -8.16 Mn |
| Jun 30, 2025 | -8.16 Mn |
| Mar 31, 2025 | -4.50 Mn |
| Mar 31, 2025 | -4.50 Mn |
| Dec 31, 2024 | -9.07 Mn |
| Dec 31, 2024 | -9.07 Mn |
| Sep 30, 2024 | -555,000.00 |
| Sep 30, 2024 | -555,000.00 |
| Jun 30, 2024 | 15.26 Mn |
| Jun 30, 2024 | 15.26 Mn |
| Mar 31, 2024 | -24.26 Mn |
| Mar 31, 2024 | -24.26 Mn |